Thrombotic Complications in Three Hemodialysis Patients With Heparin-Induced Thrombocytopenia Type I

Abstract

Although unfractionated heparin is the most commonly used anticoagulant for hemodialysis and has been associated with bleeding episodes, a more devastating complication that can occur is heparin-induced thrombocytopenia (HIT). It is believed that HIT type II is much more dangerous than type I, because HIT type II is associated with thromboembolic complications whereas there are no such complications in HIT type I. However, increased clot formation in the extracorporeal circuit during hemodialysis with unfractionated heparin is sometimes experienced by not only patients with HIT type II but also those with HIT type I. Three patients with HIT type I are presented who suffered from clot formation during hemodialysis, and in whom 81 mg of aspirin and/or cessation of heparin was prescribed. All three patients had received recombinant human erythropoietin (rHuEpo). Both heparin and rHuEpo induce enhanced platelet aggregation; therefore, it is possible that even HIT type I patients may suffer clot formation in the extracorporeal circuit due to platelet activation via the synergistic effects of unfractionated heparin and rHuEpo.

Keywords

Heparin-induced thrombocytopenia Recombinant human erythropoietin Hemodialysis Nafamostat mesilate Argatroban

References

1. Amiral J , Bridley F , Wolf M , et al. Antibodies to macromolecular platelet factor4-heparin complexed in heparininduced thrombocytopenia: A study of 44 cases. Thromb Haemost 1995;73:21-21.

2. Brieger D , Mak K , Kottke-Marchant K . Heparin-induced thrombocytopenia. J Am Coll Cardiol 1998;31:1449-1449.

3. Chong B . Heparin-induced thrombocytopenia. Aust NZ J Med 1992;22:145-145.

4. Heinrich D , Gorg T , Schulz M . Effects of unfractionated and fractionated heparin on platelet function. Haemostasis 1988;18(suppl 3):48-48.

5. Greinacher A , Warkentin T . Treatment of heparin-induced thrombocytopenia: An overview. In: Warkentin T , Greinacher A , eds. Heparin-Induced Thrombocytopenia, 2nd ed. New York: Marcel Dekker, 2001.

6. Yamamoto S , Koide M , Matsuo M , et al. Heparin-induced thrombocytopenia in hemodialysis patients. Am J Kidney Dis 1996;28:82-82.

7. Chong B , Brugess J , Ismail F . The clinical usefulness of platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 1993;69:344-344.

8. Matsuo T , Matsuo M , Ouga-Maruyama S . Can nafamostat mesilate be used for temporary management of hemodialysis in a patient with heparin-induced thrombocytopenia (HIT)? Thromb Haemost 2001;86: 1115-1115.

9. Matsuo T , Kario K , Chikahira Y , Nakao K , Yamada T . Treatment of heparin-induced thrombocytopenia by use of argatroban, a synthetic thrombin inhibitor. Br J Haematol 1992;82:627-627.

10.

10. Burgess J , Chong B . The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controls. Eur J Haematol 1997;58:279-279.

11.

11. Salzman E , Rosenberg R , Smith M , Lindon J , Favreau L . Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 1980;65:64-64.

12.

12. Eschbach J . The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin. Kidney Int 1989;35:134-134.

13.

13. Sayinalp N , Erdem Y , Ilhami O , et al. Recombinant human erythropoietin increases platelet aggregation in chronic hemodialysis patients. Thromb Res 1998;90:195-195.

14.

14. Zirkman D , Zeigler Z , Fraley D , Bruns F , Adle S . Evaluation of platelet hyperfunction in hemodialysis patients receiving recombinant human erythropoietin. Am J Kidney Dis 1993;21:31-31.

15.

15. Taylor J , Belch J , McLaren M , Henderson I , Stewar TW . Effect of erythropoietin therapy and withdrawal on blood coagulation and fibrinolysis in hemodialysis patients. Kidney Int 1993;44:182-182.

16.

16. Matsuo T , Matsuo M , Kario K , Suzuki S . Characteristics of heparin-induced platelet aggregates in chronic hemodialysis with long-term heparin use. Haemostasis 2000;30:249-249.

17.

17. Kooistra M , van EA , Marx J , Hertsig M , Struyvenberg A . Low-dose aspirin does not prevent thrombovascular accidents in low-risk haemodialysis patients during treatment with recombinant human erythropoietin. Nephrol Dial Transplant 1994;9:1115-1115.